Why You're Not Hungry on a GLP-1 — and What It Does to Your Glucose
“It is better to discuss how far you have walked than how little you have eaten.”
GLP-1s reduce hunger by slowing how fast your stomach empties and by signaling fullness to your brain. That's expected, not a malfunction. It usually means smaller, slower glucose rises after meals, but eating too little can leave you shaky and under-fueled.
One of the first things people notice on a GLP-1 is that food just stops calling. Meals you used to crave feel like a chore. That appetite drop is the drug working as designed, and it has a direct effect on your glucose too.
Why the hunger disappears
GLP-1 is a gut hormone your body already makes after eating. The drug amplifies its signal, and that signal does two things. It slows how fast your stomach empties, so you feel full longer after a meal. And it acts on appetite centers in the brain, turning down the drive to eat in the first place (Thomas 2023). Together, that's why a normal portion suddenly feels like too much and snacking loses its pull.
What it does to your blood sugar
The same mechanism that kills hunger also smooths your glucose. Because food leaves your stomach more slowly, the sugar from a meal trickles into your bloodstream instead of flooding it, so your post-meal rise is lower and gentler. Eating less overall reduces the total glucose load too. On a CGM, this often looks like flatter curves after meals, which is the appetite effect and the glucose effect coming from the same source.
When "not hungry" becomes a problem
Appetite loss is expected, but it has a floor. Eating far too little can leave you low on energy, dehydrated, and feeling shaky or dizzy, and it can cost you muscle if you're not getting enough protein. The goal isn't to eat as little as possible. It's to eat enough of the right things while the drug takes the edge off your appetite. A few practical habits help: prioritize protein at each meal, drink water deliberately since thirst can fade along with hunger, and don't skip meals entirely just because you're not hungry.
What to watch for
Reduced appetite is fine. What's worth attention is persistent nausea that stops you eating almost anything, signs of dehydration, or feeling weak and shaky between meals. Those are reasons to check in with your clinician, who may adjust your dose or your eating plan. Losing weight is the point, but doing it while under-fueled isn't a good trade.
See how your meals actually land
The interesting part is watching which foods still move your glucose now that you're eating less. Endobits reads your CGM and shows you how your smaller meals actually behave, so you can eat enough of the right things while the drug does its work. Start with Endobits →
Sources
- Thomas MC, Coughlan MT, Cooper ME. The postprandial actions of GLP-1 receptor agonists. Cell Metabolism, 2023. 10.1016/j.cmet.2023.01.004